Why start with immune recognition?
Many solid tumors evade immune recognition. Here is why LurexBio starts upstream, at the recognition step other immunotherapies depend on.
Lurex Bio Announces Patent Filings and a New Frontier in Immune Engineering
Lurex Bio has filed multiple U.S. provisional patent applications covering its immune-signal and vesicle-based targeting systems, its first step toward international protection und